European LifeCare Group (ELCG) is Europe’s largest independent provider of vaccinations, with a vision to create opportunities for everyone to be vaccinated. The company aims to make prevention and treatment easy, accessible, and safe. It operates over 50 specialist clinics in Denmark and the UK, including Danske Lægers Vaccinations Service, CityDoc, and London Travel Clinic. In addition, ELCG has more than 140 in-pharmacy clinics across the UK. As a contracted service provider of immunization programs in schools and national influenza vaccination programs for both the Danish and English NHS, ELCG plays a crucial role in public health. ELCG's focus on preventive healthcare is highlighted by its efforts in introducing new vaccines such as the HPV vaccine for cervical cancer prevention and participation in addressing prevailing health threats like Covid. These initiatives align with the company’s mission to fight disease and save lives through vaccination. The last investment, a Private Equity Round investment in November 2018, was led by Inflexion Partners, signifying confidence in ELCG's potential for growth and impact. With the increasing importance of preventive healthcare, ELCG stands in a promising position for further development and market influence within the healthcare industry.
No recent news or press coverage available for European LifeCare Group.